{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:06:28Z","timestamp":1779512788809,"version":"3.53.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012041","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.coi.2026.102748","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:43:21Z","timestamp":1773182601000},"page":"102748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-2472","authenticated-orcid":false,"given":"Claudia","family":"Grossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-1510","authenticated-orcid":false,"given":"Imogen IH","family":"Buckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1712-9957","authenticated-orcid":false,"given":"Thomas CR","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102748_sbref1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0042-1760333","article-title":"Evolution of antiphospholipid syndrome","volume":"49","author":"Arachchillage","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.coi.2026.102748_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2025.152768","article-title":"Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"74","author":"Cobanoglu","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102748_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100610","article-title":"The role of beta-2-glycoprotein I in health and disease associating structure with function: more than just APS","volume":"39","author":"McDonnell","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.coi.2026.102748_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10238-024-01359-3","article-title":"The role of anti-citrullinated protein antibody in pathogenesis of RA","volume":"24","author":"Ma","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.coi.2026.102748_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fimmu.2016.00035","article-title":"Clearance deficiency and cell death pathways: a model for the pathogenesis of SLE","volume":"7","author":"Mahajan","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102748_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jtha.2023.02.011","article-title":"Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura","volume":"21","author":"Underwood","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000738","article-title":"Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage","volume":"9","author":"McDonnell","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.coi.2026.102748_bib8","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/rheumatology\/keac596","article-title":"Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events","volume":"62","author":"Farina","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2026.102748_sbref9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321405","article-title":"Beyond antibodies: beta-2 glycoprotein I as the unsung guardian of pregnancy","volume":"20","author":"Yagi","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2026.102748_bib10","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jtha.2025.02.015","article-title":"Plasmin cleavage of \u03b22-glycoprotein I alters its structure and ability to bind to pathogenic antibodies","volume":"23","author":"Bradford","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100890","article-title":"An allosteric redox switch in domain V of \u03b22-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition","volume":"297","author":"Kumar","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102748_bib12","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1038\/s41598-021-84021-2","article-title":"Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding","volume":"11","author":"Buchholz","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102748_bib13","article-title":"The J-shape of \u03b22GPI reveals a cryptic discontinuous epitope across domains I and II","volume":"12","author":"Lalaurie","year":"2025","journal-title":"J Struct Biol X"},{"key":"10.1016\/j.coi.2026.102748_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/art.24361","article-title":"Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells","volume":"60","author":"Reed","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102748_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12959-016-0115-z","article-title":"Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome","volume":"14","author":"El-Assaad","year":"2016","journal-title":"Thromb J"},{"key":"10.1016\/j.coi.2026.102748_bib16","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.2024024469","article-title":"Protection of \u03b22GPI-deficient mice from thrombosis reflects a defect in PAR3-facilitated platelet activation","volume":"145","author":"Kulkarni","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102748_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102747","article-title":"\u0392eta-2-glycoprotein I exerts antithrombotic function through its domain V in mice","volume":"126","author":"Passam","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2026.102748_sbref18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-024-04809-2","article-title":"The protective effect of apolipoprotein H in paediatric sepsis","volume":"28","author":"Yu","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.coi.2026.102748_sbref19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.21873\/cdp.10389","article-title":"The prognostic significance of plasma beta2-glycoprotein I levels in hepatocellular carcinoma patients","volume":"4","author":"Hsieh","year":"2024","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.coi.2026.102748_sbref20","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.21873\/anticanres.16521","article-title":"Correlation of beta2-glycoprotein I with tumor prognosis in breast cancer patients","volume":"43","author":"Lee","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.coi.2026.102748_bib21","article-title":"Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis","volume":"15","author":"Garcinu\u00f1o","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2026.102748_bib22","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/cas.14030","article-title":"Structural and functional characterization of \u03b22-glycoprotein I domain 1 in anti-melanoma cell migration","volume":"110","author":"Leu","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.coi.2026.102748_bib23","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","article-title":"\u03b2\u2082-glycoprotein I: a novel component of innate immunity","volume":"117","author":"Agar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102748_bib24","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1177\/0271678X20984551","article-title":"\u03b22 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke","volume":"41","author":"Grossi","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.coi.2026.102748_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109714","article-title":"Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps","volume":"255","author":"Kme\u0165ov\u00e1","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2026.102748_bib26","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2009-04-215335","article-title":"Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury","volume":"116","author":"Ioannou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102748_sbref27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293304","article-title":"\u03b22-glycoprotein I promotes the clearance of circulating mitochondria","volume":"19","author":"Dasgupta","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2026.102748_bib28","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/pro.4054","article-title":"Cardiolipin interacts with beta-2-glycoprotein I and forms an open conformation\u00a0\u2014 mechanisms analyzed using hydrogen\/deuterium exchange","volume":"30","author":"Tang","year":"2021","journal-title":"Protein Sci"},{"key":"10.1016\/j.coi.2026.102748_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2026.102748_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.70066","article-title":"The mechanisms and implications of cardiolipin in the regulation of cell death","volume":"43","author":"Li","year":"2025","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.coi.2026.102748_bib31","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1097\/CCM.0000000000003636","article-title":"Lipidomics detection of brain cardiolipins in plasma is associated with outcome after cardiac arrest","volume":"47","author":"Anthonymuthu","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.coi.2026.102748_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41467-018-03241-9","article-title":"Cardiolipin exposure on the outer mitochondrial membrane modulates \u03b1-synuclein","volume":"9","author":"Ryan","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102748_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0143-4004(97)80040-9","article-title":"Synthesis of beta2 glycoprotein 1 by the human placenta","volume":"18","author":"Chamley","year":"1997","journal-title":"Placenta"},{"key":"10.1016\/j.coi.2026.102748_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102681","article-title":"Trophoblast cell function in the antiphospholipid syndrome","volume":"11","author":"Vrzi\u0107 Petronijevi\u0107","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.coi.2026.102748_bib35","article-title":"OxLDL\/\u03b22GPI\/anti\u2011\u03b22GPI Ab complex induces inflammatory activation via the TLR4\/NF\u2011\u03baB pathway in HUVECs","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.coi.2026.102748_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2011.09.004","article-title":"IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells","volume":"38","author":"Yan","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2026.102748_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cytogfr.2023.12.007","article-title":"Navigating IL-6: from molecular mechanisms to therapeutic breakthroughs","volume":"76","author":"Swaroop","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.coi.2026.102748_bib38","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1182\/blood-2003-08-2712","article-title":"Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis","volume":"103","author":"Yasuda","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102748_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102675","article-title":"Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: implications for thrombosis risk","volume":"122","author":"Krilis","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.coi.2026.102748_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/cei.12762","article-title":"Antibodies to age-\u03b22 glycoprotein I in patients with anti-phospholipid antibody syndrome","volume":"184","author":"Sorice","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2026.102748_bib41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jcp.53.11.863","article-title":"Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardium","volume":"53","author":"Niessen","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.coi.2026.102748_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.235","article-title":"Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia\/reoxygenation injury model via p38 MAPK","volume":"8","author":"Bourke","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coi.2026.102748_bib43","article-title":"Antiphospholipid antibodies exacerbate damage following oxygen deprivation-reperfusion injury in an in vivo model for stroke and in ex vivo blood derived endothelial cells","author":"Pericleous","year":"2024","journal-title":"MedRxiv"},{"key":"10.1016\/j.coi.2026.102748_bib44","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102748_bib45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2019.221945","article-title":"Seronegative antiphospholipid syndrome: refining the value of \"non-criteria\" antibodies for diagnosis and clinical management","volume":"105","author":"Pignatelli","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2026.102748_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.9585","article-title":"Seronegative antiphospholipid syndrome: a challenging case report","volume":"12","author":"Subahi","year":"2024","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.coi.2026.102748_bib47","article-title":"Seronegative obstetric antiphospholipid syndrome finally treated successfully","volume":"9","author":"Alghanim","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.coi.2026.102748_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11596-018-1889-y","article-title":"Thrombophilia caused by beta2-glycoprotein I deficiency: in vitro study of a rare mutation in APOH gene","volume":"38","author":"Zhang","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.coi.2026.102748_bib49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/1096-8652(200010)65:2<160::AID-AJH12>3.0.CO;2-8","article-title":"Primary antiphospholipid antibody syndrome with mutations in the phospholipid binding domain of beta(2)-glycoprotein I","volume":"65","author":"Gushiken","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.coi.2026.102748_bib50","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1538-7836.2008.03000.x","article-title":"Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain","volume":"6","author":"Yu","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3324\/haematol.2018.213991","article-title":"Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort","volume":"105","author":"Gris","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2026.102748_bib52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/ejh.14096","article-title":"Antiphospholipid syndrome in cardiovascular disease and cancer","volume":"111","author":"Pessach","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.coi.2026.102748_sbref53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167739","article-title":"Conditional deletion of Pink1 in mesenchymal stem cells suppresses osteogenesis through downregulation of Apoh transcription","volume":"1871","author":"Zhang","year":"2025","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.coi.2026.102748_sbref54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41419-024-07099-2","article-title":"Serum apolipoprotein H determines ferroptosis resistance by modulating cellular lipid composition","volume":"15","author":"He","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coi.2026.102748_bib55","doi-asserted-by":"crossref","first-page":"10751","DOI":"10.3390\/ijms251910751","article-title":"Plasma proteomic biomarkers in Alzheimer's disease and cardiovascular disease: a longitudinal study","volume":"25","author":"Theeke","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2026.102748_bib56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fnagi.2017.00250","article-title":"Presence of anticardiolipin antibodies in patients with dementia: a systematic review and meta-analysis","volume":"9","author":"Islam","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.coi.2026.102748_bib57","article-title":"Apolipoprotein H deficiency exacerbates alcohol-induced liver injury via gut Dysbiosis and altered bile acid metabolism","volume":"1869","author":"Liu","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.coi.2026.102748_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100483","article-title":"Effects of apolipoprotein H downregulation on lipid metabolism, fatty liver disease, and gut microbiota dysbiosis","volume":"65","author":"Liu","year":"2024","journal-title":"J Lipid Res"},{"key":"10.1016\/j.coi.2026.102748_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jri.2018.04.002","article-title":"Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus","volume":"127","author":"Mayer-Pickel","year":"2018","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.coi.2026.102748_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111389","article-title":"Developing the biomarker panels and drugs by proteomic analysis for autoimmune uveitis and posterior scleritis","volume":"27","author":"Li","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.coi.2026.102748_bib61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.autrev.2006.11.005","article-title":"Ocular manifestations in antiphospholipid syndrome","volume":"6","author":"Suvajac","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.coi.2026.102748_bib62","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/bjo.2010.182857","article-title":"Ocular manifestations of the antiphospholipid syndrome","volume":"95","author":"Utz","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.coi.2026.102748_bib63","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.23387","article-title":"Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies","volume":"58","author":"Rahgozar","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102748_bib64","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1074\/jbc.M110176200","article-title":"Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome","volume":"277","author":"Guerin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102748_bib65","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2026.102748_bib66","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1191\/0961203303lu397oa","article-title":"Activation of complement mediates antiphospholipid antibody-induced pregnancy loss","volume":"12","author":"Salmon","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.coi.2026.102748_bib67","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.bbapap.2013.06.009","article-title":"Identification of the binding site for fondaparinux on Beta2-glycoprotein I","volume":"1834","author":"Kolyada","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coi.2026.102748_bib68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0038-1648918","article-title":"The interaction of beta 2 glycoprotein-I and heparin and its effect on beta 2 glycoprotein-I antiphospholipid antibody cofactor function in plasma","volume":"72","author":"McNally","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40800-016-0031-y","article-title":"Anticoagulation therapy considerations in factor VII deficiency","volume":"3","author":"Paulus","year":"2016","journal-title":"Drug Saf Case Rep"},{"key":"10.1016\/j.coi.2026.102748_bib70","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jth.12238","article-title":"\u03b22-Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions","volume":"11","author":"Pozzi","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib71","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coi.2026.102748_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117968","article-title":"S-hydroxychloroquine prevents the antiphospholipid thrombogenic complexes for antiphospholipid syndrome treatment","volume":"186","author":"Hsieh","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coi.2026.102748_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021331","article-title":"Hydroxychloroquine as an immunomodulatory and antithrombotic treatment in antiphospholipid syndrome","volume":"24","author":"Arachchillage","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2026.102748_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1298928","article-title":"Deciphering the immunological interactions: targeting preeclampsia with hydroxychloroquine's biological mechanisms","volume":"15","author":"Gaji\u0107","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coi.2026.102748_bib75","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/j.1538-7836.2010.03944.x","article-title":"Redox control of \u03b22-glycoprotein I-von Willebrand factor interaction by thioredoxin-1","volume":"8","author":"Passam","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib76","article-title":"Reduction of HLA class II expression and beta-2-glycoprotein I presentation by fluvastatin in vitro and in vivo: possible mechanism of statin-induced-deprocoagulation in the antiphospholipid syndrome [abstract]","volume":"67","author":"Watanabe","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102748_bib77","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Y","article-title":"Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype","volume":"44","author":"Meroni","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102748_bib78","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1538-7836.2004.00896.x","article-title":"Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells","volume":"2","author":"Ferrara","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.coi.2026.102748_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081288","article-title":"Anti-\u03b22-GPI antibodies induce endothelial cell expression of tissue factor by LRP6 signal transduction pathway involving lipid rafts","volume":"11","author":"Riitano","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.coi.2026.102748_bib80","article-title":"Lipid rafts disruption by statins negatively impacts the interaction between SARS-CoV-2 S1 subunit and ACE2 in intestinal epithelial cells","volume":"14","author":"El Khoury","year":"2023","journal-title":"Front Microbiol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:24:54Z","timestamp":1779510294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":80,"alternative-id":["S0952791526000257"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102748","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102748"}}